Business Description
Arzneiwerk AG VIDA
NAICS : 423450
SIC : 5122
ISIN : DE000A289B07
Description
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -0.46 | |||||
| Debt-to-Equity | -2.04 | |||||
| Debt-to-EBITDA | -13.42 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -3.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -25.4 | |||||
| 3-Year EPS without NRI Growth Rate | -132.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.35 | |||||
| 9-Day RSI | 34.7 | |||||
| 14-Day RSI | 36.14 | |||||
| 6-1 Month Momentum % | -20.48 | |||||
| 12-1 Month Momentum % | -45.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | |||||
| Quick Ratio | 0.17 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 5989.22 | |||||
| Days Sales Outstanding | 172.91 | |||||
| Days Payable | 1322.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.6 | |||||
| Shareholder Yield % | -26.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.29 | |||||
| Operating Margin % | -39.14 | |||||
| Net Margin % | -82.62 | |||||
| FCF Margin % | 94.76 | |||||
| ROA % | -15.78 | |||||
| ROIC % | -5.9 | |||||
| 3-Year ROIIC % | -56.36 | |||||
| ROC (Joel Greenblatt) % | -33.04 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 8.29 | |||||
| PS Ratio | 2.21 | |||||
| Price-to-Free-Cash-Flow | 2.33 | |||||
| Price-to-Operating-Cash-Flow | 2.25 | |||||
| EV-to-EBIT | -10.64 | |||||
| EV-to-EBITDA | -17.4 | |||||
| EV-to-Revenue | 7.16 | |||||
| EV-to-FCF | 7.89 | |||||
| Earnings Yield (Greenblatt) % | -9.41 | |||||
| FCF Yield % | 49.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arzneiwerk AG VIDA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.1 | ||
| EPS (TTM) (€) | -0.285 | ||
| Beta | 1.79 | ||
| Volatility % | 32.87 | ||
| 14-Day RSI | 36.14 | ||
| 14-Day ATR (€) | 0.075243 | ||
| 20-Day SMA (€) | 0.8 | ||
| 12-1 Month Momentum % | -45.07 | ||
| 52-Week Range (€) | 0.61 - 1.75 | ||
| Shares Outstanding (Mil) | 6.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arzneiwerk AG VIDA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arzneiwerk AG VIDA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arzneiwerk AG VIDA Frequently Asked Questions
What is Arzneiwerk AG VIDA(STU:TLIK)'s stock price today?
The current price of STU:TLIK is €0.69. The 52 week high of STU:TLIK is €1.75 and 52 week low is €0.61.
When is next earnings date of Arzneiwerk AG VIDA(STU:TLIK)?
The next earnings date of Arzneiwerk AG VIDA(STU:TLIK) is .
Does Arzneiwerk AG VIDA(STU:TLIK) pay dividends? If so, how much?
Arzneiwerk AG VIDA(STU:TLIK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers